To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

Clinical trial NCT05483907 · COMPLETED

Trial details

NCT number: NCT05483907
Sponsor: Bridge Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-04-12
Primary completion: 2025-01-26
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.